Cal-Maine Foods Reports FY2026 Results: Earnings Collapse Confirms Cycle Trough

What happened

Cal-Maine Foods reported its fourth quarter and fiscal 2026 results, showing a sharp decline in earnings as egg prices normalized from record highs. The company's realized shell-egg prices remained under $2.00 per dozen, consistent with the oversupplied market condition flagged in our prior analysis. While the company continues to build its prepared foods segment, the financial impact remains dominated by commodity egg pricing. The antitrust settlement with the DOJ, which included no fines, removes a major overhang but does not change the near-term earnings trajectory. Overall, the results reinforce the view that CALM’s earnings power is currently depressed and that a recovery depends on pricing stabilization and margin improvement from diversification.

Implication

Over the next six to twelve months, the key catalysts are the Tunney Act settlement finalization and observable stabilization in realized egg prices. If the company can maintain its net cash position and continue buybacks, the downside is limited. However, without a price recovery, earnings will remain compressed, and the prepared foods segment must prove it can contribute sustainably to margins. The balance sheet provides a buffer, but the core commodity exposure means the stock is a cyclical bet. Investors should wait for at least two quarters of improving pricing data before increasing exposure.

Thesis delta

The FY2026 results confirm our existing thesis that CALM is in a cyclical trough, and the settlement removes only the antitrust headline risk. No material shift in the investment case occurs; the WAIT rating remains appropriate pending pricing stabilization. The key new data point is the full-year earnings figure, but it aligns with our bearish base case.